MIRTAZAPINE | A216751 | PRASCO LLC DBA PRASCO LABORATORIES
Highest NADAC/Unit
$0.3613
per ea
Lowest NADAC/Unit
$0.0658
per ea
Brand NDCs
0
Generic NDCs
8
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 66993060604MIRTAZAPINE 7.5 MG TABLET | $0.3613 | EA | Generic | — | 2026-06-17 |
| 66993060630MIRTAZAPINE 7.5 MG TABLET | $0.3613 | EA | Generic | — | 2026-06-17 |
| 66993060930MIRTAZAPINE 45 MG TABLET | $0.1078 | EA | Generic | — | 2026-06-17 |
| 66993060904MIRTAZAPINE 45 MG TABLET | $0.1078 | EA | Generic | — | 2026-06-17 |
| 66993060804MIRTAZAPINE 30 MG TABLET | $0.0887 | EA | Generic | — | 2026-06-17 |
| 66993060830MIRTAZAPINE 30 MG TABLET | $0.0887 | EA | Generic | — | 2026-06-17 |
| 66993060704MIRTAZAPINE 15 MG TABLET | $0.0658 | EA | Generic | — | 2026-06-17 |
| 66993060730MIRTAZAPINE 15 MG TABLET | $0.0658 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.